Inventor profile of:

Joanne Wang

City:

Irvine, California

Country:

United States

Published Applications:

42

Last publication date:

2024-08-15

Top Assignees for applications by Joanne Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Joanne:

Recent patent applications by Wang Joanne

Joanne Wang from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-15
US20240272160A1
Physics

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

#2 | 2023-10-12
US20230323290A1
Chemistry; metallurgy

CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#3 | 2023-09-28
US20230302103A1
Human necessities

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#4 | 2023-09-07
US20230279083A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#5 | 2023-07-27
US20230235031A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#6 | 2022-05-12
US20220144925A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#7 | 2021-11-04
US20210340229A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

#8 | 2021-06-10
US20210172952A1
Physics

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

#9 | 2021-06-10
US20210171614A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

#10 | 2021-06-03
US20210163887A1
Chemistry; metallurgy

CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#11 | 2021-06-03
US20210162027A1
Human necessities

BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN

#12 | 2020-12-17
US20200392212A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#13 | 2020-11-26
US20200369749A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#14 | 2019-10-24
US20190324041A1
Physics

Immuno-based retargeted endopeptidase activity assays

#15 | 2018-12-06
US20180344820A1
Human necessities

Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin

#16 | 2017-10-05
US20170283487A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

#17 | 2017-08-31
US20170248602A1
Physics

Immuno-based retargeted endopeptidase activity assays

#18 | 2017-08-03
US20170218334A1
Chemistry; metallurgy

Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays

#19 | 2015-10-22
US20150301050A1
Physics

Immuno-based retargeted endopeptidase activity assays

#20 | 2014-09-04
US20140248644A1
Physics

Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A

#21 | 2014-04-03
US20140093957A1
Physics

Cells useful for immuno-based botulinum toxin serotype a activity assays

#22 | 2013-10-10
US20130267010A1
Chemistry; metallurgy

Immuno-Based Retargeted Endopeptidase Activity Assays

#23 | 2013-09-12
US20130236963A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#24 | 2013-02-14
US20130040368A1
Chemistry; metallurgy

IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

#25 | 2012-09-06
US20120225436A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

#26 | 2012-08-23
US20120214231A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#27 | 2012-08-23
US20120214229A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#28 | 2012-08-16
US20120208272A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#29 | 2012-08-16
US20120208271A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#30 | 2012-06-28
US20120164728A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#31 | 2012-06-21
US20120156776A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#32 | 2012-06-21
US20120156775A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#33 | 2012-06-21
US20120156774A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#34 | 2012-06-21
US20120156769A1
Chemistry; metallurgy

Cells useful for immuno-based Botulinum toxin serotype A activity assays

#35 | 2012-06-14
US20120149106A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#36 | 2012-06-14
US20120149105A1
Chemistry; metallurgy

Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays

#37 | 2012-06-14
US20120149104A1
Chemistry; metallurgy

Cells useful for immuno-based botulinum toxin serotype A activity assays

#38 | 2012-06-14
US20120149103A1
Chemistry; metallurgy

Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays

#39 | 2012-05-17
US20120122128A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

#40 | 2010-09-16
US20100233802A1
Chemistry; metallurgy

Cells useful for immuno-based Botulinum toxin serotype A activity assays

#41 | 2010-09-16
US20100233741A1
Physics

Immuno-based retargeted endopeptidase activity assays

#42 | 2010-08-12
US20100203559A1
Chemistry; metallurgy

Immuno-based botulinum toxin serotype A activity assays

InventorID:

90392 ⎘